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Summary
We used 66 pregnant sows to compare
serum progesterone concentrations follow-
ing a single injection of either saline or one
of two prostaglandin F2a  products ap-
proved for use in swine.  Pregnant sows in
a commercial swine farm were assigned to
one of the three groups in a completely
randomized design balanced across treat-
ment for parity and day of gestation.  Each
sow received a single intramuscular dose
(2 mL) on d 111, 112, or 113 of gestation.
Mean serum progesterone concentrations
were decreased significantly at 6 and
12 hours after dose administration of both
prostaglandin products.  However, these
effects did not differ.  Serum progesterone
concentrations did not decrease signifi-
cantly at any time in the control group.
This indicates that regression of corpora
lutea was initiated at the same time by both
prostaglandin products.
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Introduction
This study was conducted to compare
progesterone blood levels in pregnant sows
following a single injection of either a
generic (Prostamate™, Phoenix Scientific,
Inc.) or originally marketed (Lutalyse®,
Pharmacia & Upjohn Company) prosta-
glandin product (dinoprost tromethamine)
approved for use in swine. This prostaglan-
din is used commonly on swine farms to
induce farrowing.
Procedures
The study was conducted on a com-
mercial swine operation (Global Ventures,
Inc.) in Pipestone, Minnesota. Sows were
housed individually in environmentally
controlled farrowing facilities.  Water was
provided ad libitum, and feed was offered
at least three times daily according to the
farm’s standard procedures. On the day
prior to dosing, animal identification,
farrowing date, and parity were confirmed,
and animals were assigned randomly to
treatment groups balanced across day of
gestation and parity.  Sows that had al-
ready farrowed or were off feed were
excluded from the study. Sixty-six preg-
nant sows were assigned  randomly to one
of three dose groups.  Identity of the test
materials (saline, ProstaMate™ and
Lutalyse®) was not revealed to KSU per-
sonnel or farm staff until after the trial had
concluded.  Each sow received a single
intramuscular dose (2 mL) of her assigned
product on d 111, 112, or 113 (Day 0 was
onset of estrus) of gestation.  The KSU
staff administering the injections knew
only the group designation (1, 2, or 3). The
farrowing supervisor observed all gilts and
sows at least once daily for general health
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and appearance from 2 days before to 5
days after administration of the test materi-
als.
Blood samples were collected from
each animal via the anterior vena cava or
jugular vein prior to dosing and at approxi-
mately 6 and 12 hours after dose adminis-
tration.  Concentrations of serum proges-
terone were analyzed using a
radioimmunoassay technique. The data
were analyzed using a repeated measures
mixed effects model in SAS® The fixed
effects included treatment (1, 2, or 3); time
period after treatment administration (0, 6,
or 12 hours); and the interaction between
treatment and time period. The sow within
treatment term was specified as a random
effect. The means were reported as least
square means using a Satterthwaite correc-
tion for the degrees of freedom. 
Results and Discussion
The farrowing supervisor noted no
abnormal behavior in any of the study
animals.  She noted that animals in Groups
2 and 3 showed more agitation along with
chewing and nesting behaviors prior to
farrowing, although she did not document
any differences between those two groups.
Two days after dosing, she accurately
guessed that animals in Group 1 received
the saline, because they did not exhibit
these behaviors and many had not yet
farrowed.
Mean serum progesterone concentra-
tions were decreased significantly at 6 and
12 hours after administration of both pros-
taglandin products (Table 1).  However, no
statistically significant differences
occurred between the effects of the two
products.  Mean serum progesterone con-
centrations did not decrease significantly at
any time in the control (saline) group.  The
serum concentrations of progesterone in
this study indicate that luteolysis or regres-
sion of the copora lutea of pregnancy was
initiated at the same time for both prod-
ucts.  Because this is the initial mechanism
leading to farrowing after prostaglandin
injection, the two products should be
equally efficacious for induction of farrow-
ing.
Table 1. Effects of Prostaglandin Products on Serum Progesterone  Concentrations in
Pregnant Sows (ng/mL )a
Time (hr)
Group 1
(saline)
Group 2
(Prostamate™)
Group 3
(Lutalyse®)
0 479 4.58x 4.46x
6 451 4.01y 3.92y
12 4.51b 2.96c,z 2.46c,z
SEM ±0.21 ±0.21 ±0.22
N 22 23 21
aTime by treatment interaction (P<0.001).
b,cMeans within rows with unlike superscripts are significantly different (P<0.05).
x,y,zMeans within columns with unlike superscripts are significantly different (P<0.05).
N=number of sows dosed.
